45 results on '"R. Liberge"'
Search Results
2. Les cryobiopsies pulmonaires transbronchiques dans les pneumopathies infiltrantes diffuses
- Author
-
C. Menigoz, S. Dirou, C. Sagan, F. Corne, A. Moui, C. Defrance, R. Liberge, O. Morla, V. Patarin, A. Nicolas, C. Kandel-Aznar, P. Lacoste, J.P. Clarke, A. Cavailles, L. Cellerin, and F.-X. Blanc
- Subjects
Pulmonary and Respiratory Medicine - Published
- 2023
- Full Text
- View/download PDF
3. No benefit of a prolonged course of corticosteroids in patients with COVID-19 secondary organizing pneumonia
- Author
-
B Artignan, S Dirou, M Wargny, A Moui, V Danielo, C Defrance, R Liberge, O Morla, M Chauveau, P Le Turnier, A Asquier Khati, A Espitia Thilbault, M Artifoni, M Agbakou, L Desmedt, A S Boureau, E Eschapasse, and F Blanc
- Published
- 2022
- Full Text
- View/download PDF
4. [Immune-related pneumonitis: A differential diagnosis of SARS-CoV-2 pneumonia]
- Author
-
B, Nigen, A-L, Chéné, R, Liberge, C, Sagan, and F-X, Blanc
- Subjects
Diagnosis, Differential ,COVID-19 Testing ,Adrenal Cortex Hormones ,SARS-CoV-2 ,Neoplasms ,COVID-19 ,Humans ,Pneumonia - Abstract
Immune checkpoint inhibitors have revolutionized the management of many cancers and achieved efficacy and durable response for some patients, including those with advanced cancers. However, immunotherapy is associated with side effects caused by the infiltration of immune cells into normal tissues, which can lead to disproportionate dysimmune reactions. While mostly of moderate intensity, these side effects can affect any organ, including the lung, the site of occasionally life-threatening interstitial lung disease. Their presentation can be similar to that of infectious pneumonia (COVID-19).We report the cases of 3 patients who presented between March and May 2020 with severe pulmonary toxicities secondary to immunotherapy, which led to with an initial hypothesis of SARS-CoV-2 pneumonia. After extensive investigations, the diagnosis of pulmonary toxicity to immunotherapy was given, and the clinical and radiological course following the initiation of corticosteroid therapy was favorable.Pulmonary toxicity secondary to immunotherapy remains a rare but potentially life-threatening side effect. The diagnostic approach requires the elimination of several differential diagnoses (infectious process, tumor progression, other etiologies of interstitial lung disease). This adverse event is reversible and evolution after initiation of corticosteroid therapy is usually favorable.
- Published
- 2022
5. Une télangiectasie hémorragique héréditaire révélée tardivement par une thrombose veineuse cérébrale : à propos d'un cas
- Author
-
G. Ploton, P. Constant Dit Beaufils, Olivier Espitia, R. Liberge, Jérôme Connault, S. De Gaalon, S. Mercier, Clinique neurologique, Hôpital Laennec, Institut Jacques Monod (IJM (UMR_7592)), Université de Paris (UP)-Centre National de la Recherche Scientifique (CNRS), Service de Radiologie et imagerie médicale, and Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Raymond Poincaré [AP-HP]
- Subjects
Gynecology ,03 medical and health sciences ,medicine.medical_specialty ,0302 clinical medicine ,business.industry ,[SDV]Life Sciences [q-bio] ,Gastroenterology ,Internal Medicine ,Medicine ,030212 general & internal medicine ,business ,030217 neurology & neurosurgery ,3. Good health - Abstract
Resume Introduction La telangiectasie hemorragique hereditaire (THH) est une pathologie autosomique dominante revelee par la triade epistaxis, telangiectasie et heredite familiale. Observation Nous rapportons le cas d'un patient ayant eu une thrombophlebite cerebrale idiopathique compliquee d'infarctus cerebral traitee par warfarine. Dans le contexte d'un hematome du psoas par surdosage en anticoagulants oraux avec alitement, le patient a eu une thrombose veineuse profonde du membre inferieur gauche compliquee d'embolie pulmonaire, ayant revele une malformation arterio-veineuse pulmonaire. Apres reevaluation, le patient presentait un phenotype clinique de THH confirme genetiquement. Le patient a ete traite par rivaroxaban permettant une amelioration clinique et une repermeabilisation partielle des thromboses a 6 mois. Le sur-risque thrombotique a deja ete etudie chez les patients THH mais l'utilisation des anticoagulants est a risque chez ces patients. Neanmoins, le traitement a ete bien tolere par ce patient. Conclusion Il s'agit du premier cas decrit de thrombophlebite cerebrale revelant une THH et traitee par rivaroxaban.
- Published
- 2020
- Full Text
- View/download PDF
6. La cryobiopsie : une technique sûre et efficace pour obtenir un diagnostic face à une pneumopathie infiltrante diffuse chez la personne âgée
- Author
-
C. Menigoz, S. Dirou, C. Sagan, F. Corne, A. Moui, C. Defrance, R. Liberge, O. Morla, V. Patarin, A. Nicolas, C. Kandel-Aznar, J.P. Clarke, A. Cavailles, L. Cellerin, and F.X. Blanc
- Subjects
Pulmonary and Respiratory Medicine - Published
- 2023
- Full Text
- View/download PDF
7. Prise en charge thérapeutique des métastases osseuses en radiologie interventionnelle
- Author
-
R. Liberge, F. Douane, A. David, C. Labbe, and C. Perret
- Subjects
03 medical and health sciences ,0302 clinical medicine ,Radiological and Ultrasound Technology ,030220 oncology & carcinogenesis ,Biophysics ,Radiology, Nuclear Medicine and imaging ,030218 nuclear medicine & medical imaging - Abstract
Resume De multiples techniques de radiologie interventionnelle sont utilisees pour proposer des solutions antalgiques, consolidatrices et carcinologiques aux patients atteints de metastases osseuses. Les indications de ces traitements doivent etre discutees en reunion de concertation pluridisciplinaire, en fonction de l’objectif (curatif ou palliatif), du risque fracturaire, ainsi que de l’etat general du patient. Cet article a pour but de presenter les principales methodes disponibles pour la prise en charge des metastases osseuses. La cimentoplastie consiste a injecter du polymethylmethacrylate au sein des lesions osseuses par voie percutanee, dans un but de consolidation et de soulagement de la douleur. La thermoablation a pour objectif de detruire la lesion tumorale par le chaud (radiofrequence et micro-ondes) ou par le froid (cryotherapie), dans un but curatif ou palliatif (soulagement de la douleur). L’embolisation et la chimioembolisation arterielle consistent a devasculariser une lesion tumorale hypervasculaire, a visee antalgique ou en prevision d’une chirurgie. Les differentes techniques peuvent etre combinees dans les cas les plus complexes.
- Published
- 2017
- Full Text
- View/download PDF
8. [An hereditary hemorrhagic telangiectasia of late revealed by a cerebral venous thrombosis: A case report]
- Author
-
P, Constant Dit Beaufils, S, De Gaalon, O, Espitia, G, Ploton, S, Mercier, R, Liberge, and J, Connault
- Subjects
Male ,Venous Thrombosis ,Delayed Diagnosis ,Anticoagulants ,Middle Aged ,Pulmonary Artery ,Magnetic Resonance Imaging ,Late Onset Disorders ,Diagnosis, Differential ,Rivaroxaban ,Pulmonary Veins ,Arteriovenous Fistula ,Humans ,Telangiectasia, Hereditary Hemorrhagic ,Intracranial Thrombosis ,Pulmonary Embolism - Abstract
Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disease characterized by the triad of nose bleeding, telangiectasia and familial heredity.We report the case of a patient who had idiopathic venous cerebral thrombosis complicated by a cerebral infarction treated with warfarin. In the context of a psoas hematoma by warfarine overdose and immobilization, the patient had deep vein thrombosis of the left lower limb with pulmonary embolism revealing a pulmonary arteriovenous malformation. After a reexamination, the patient clinical phenotype of HHT was confirmed genetically. The patient was treated with rivaroxaban allowing clinical improvement and partial recanalization of all thrombosis after six months. Thrombotic overisk has already been studied in HHT patients but the use of anticoagulants is at higher risk in these patients. However this patient experienced no adverse event with rivaroxaban.This is the first case described of cerebral venous thrombosis treated with rivaroxaban revealing an HHT.
- Published
- 2019
9. Ultrasonographic guidance for portal vein access during transjugular intrahepatic portosystemic shunt (TIPS) placement
- Author
-
C. Perret, Isabelle Archambeaud, F. Douane, D. Trewick, F. Léauté, Eric Frampas, A. David, R. Liberge, O. Morla, J. Gournay, and J. Meyer
- Subjects
Adult ,Male ,medicine.medical_specialty ,Percutaneous ,medicine.medical_treatment ,Technical success ,Portal vein ,Punctures ,030218 nuclear medicine & medical imaging ,03 medical and health sciences ,Young Adult ,0302 clinical medicine ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,Ultrasonography, Interventional ,Aged ,Retrospective Studies ,Aged, 80 and over ,Radiological and Ultrasound Technology ,business.industry ,Portal Vein ,Mortality rate ,Ultrasound ,Mean age ,General Medicine ,Middle Aged ,medicine.disease ,Surgery ,030220 oncology & carcinogenesis ,Portal hypertension ,Female ,Portasystemic Shunt, Transjugular Intrahepatic ,business ,Transjugular intrahepatic portosystemic shunt - Abstract
Purpose The purpose of our study was to retrospectively assess the safety and efficacy of percutaneous real-time ultrasound guidance for portal vein puncture during transjugular intrahepatic portosystemic shunt (TIPS) placement. Materials and methods Between January 2011 and November 2018, procedure details and outcome were retrospectively analyzed for 224 patients who underwent TIPS placement using real-time ultrasound guidance for portal vein puncture. There were 175 men and 49 women with a mean age of 52.7 ± 10.6 (SD) years (range: 22–82 years). For each procedure, technical success, primary ultrasound guidance success, portosystemic pressure gradient, duration of the intervention, procedural complications, radiation exposure, mortality and morbidity rates at day 30 post-procedure were recorded for data analysis. Results Technical success rate was 100.0% with a success rate of the primary ultrasound guidance of 97.8% (219/224; 95% CI: 95.8–99.7). Mean duration of the procedure was 86.2 ± 41.7 (SD) min (range: 22.0–267.0 min). Mean dose-area product was 62.0 ± 50.2 (SD) Gy.cm2 (range: 3.7–306.5 Gy.cm2). Twelve complications (12/224; 5.4%) occurred in ten patients during TIPS procedures including 8 arterial punctures (3.6%) and 4 biliary punctures (1.8%). Four complications (4/224; 1.8%) were clinically significant. Mortality rate at day 30 after the procedure was 9.8% (22/224), without any patient dying from technical complications. Conclusion Real-time ultrasound guidance is a safe technique to assist in the creation of TIPS and may allow for lower radiation exposure.
- Published
- 2018
10. Un kyste peut en cacher un autre
- Author
-
S. Dirou, François-Xavier Blanc, D. Hassoun, Antoine Magnan, G. Quereux, L. Peuvrel, Christine Sagan, and R. Liberge
- Subjects
Pulmonary and Respiratory Medicine - Abstract
Introduction Les atteintes pulmonaires polykystiques peuvent etre d’etiologies diverses notamment infectieuse ou neoplasique. Nous rapportons ici le cas d’un diagnostic d’expression pulmonaire d’une maladie de Sezary diagnostiquee au decours d’une pneumocystose. Description Un homme de 73 ans rapporte l’apparition subaigue et l’aggravation progressive d’une dyspnee d’effort associee a une toux seche dans un contexte d’alteration de l’etat general. Il presente comme principal antecedent un syndrome de Sezary (lymphome cutane T epidermotrope) stabilise sous bexarotene et dermocorticoides. Les explorations initiales concluent a une pneumocystose devant la symptomatologie, l’atteinte radiologique compatible (verre depoli diffus et kystes pulmonaires a la tomodensitometrie thoracique) et la positivite de la PCR pneumocystis dans le lavage bronchoalveolaire (LBA). Malgre un traitement de 3 semaines par cotrimoxazole, les symptomes generaux et respiratoires persistent 3 mois plus tard. La maladie de Sezary est alors jugee comme toujours stable sur le plan cutane et biologique. Le controle tomodensitometrique retrouve une extension du verre depoli (aspect patchy), des condensations peri-bronchovasculaires migratrices et une augmentation du nombre de kystes pulmonaires. Le bilan biologique retrouve une lymphopenie profonde a 0.65 G/L et une hypereosinophilie a 0,52 G/L. Il n’y a pas de documentation microbiologique sur les prelevements endoscopiques (PCR pneumocystis negative). Le LBA retrouve une formule lymphocytaire (65 %) avec elements atypiques d’aspect sezariforme et eosinophilique (26 %) evoquant une localisation pulmonaire du syndrome de Sezary. Les biopsies transbronchiques confirment ce diagnostic par l’identification d’un infiltrat lymphoide perivasculaire de phenotype sezariforme. Une chimiotherapie par doxorubicine est initiee. A 3 mois de l’instauration de la chimiotherapie, une amelioration de l’etat general ainsi que de la dyspnee est observee. La tomodensitometrie thoracique retrouve quant a elle une nette diminution des lesions en verre depoli et une persistance de plusieurs lesions kystiques bilaterales. Conclusion Les localisations pulmonaires des lymphomes cutanes T epidermotropes sont peu decrites dans la litterature [1] . L’analyse precise du LBA peut suffire a elle seule a poser le diagnostic. L’aggravation de lesions kystiques pulmonaires en contexte de lymphome connu doit amener a eliminer une pathologie infectieuse. En l’absence d’amelioration malgre une therapeutique adaptee, une localisation pulmonaire de la pathologie lymphoproliferative doit etre recherchee.
- Published
- 2019
- Full Text
- View/download PDF
11. CT-guided direct percutaneous treatment of a ruptured pulmonary artery pseudoaneurysm using N-butyl cyanoacrylate
- Author
-
R. Liberge, C. Perret, F. Douane, A. David, and Eric Frampas
- Subjects
medicine.medical_specialty ,Percutaneous ,Radiological and Ultrasound Technology ,medicine.diagnostic_test ,business.industry ,N-butyl-cyanoacrylate ,Computed tomography ,General Medicine ,medicine.disease ,030218 nuclear medicine & medical imaging ,03 medical and health sciences ,Pseudoaneurysm ,0302 clinical medicine ,030220 oncology & carcinogenesis ,medicine.artery ,Pulmonary artery ,Medicine ,Radiology, Nuclear Medicine and imaging ,Radiology ,business - Published
- 2017
- Full Text
- View/download PDF
12. Diagnostic et traitement des fistules vertébrovertébrales
- Author
-
E. Auffray-Calvier, Hubert Desal, J. Isnard, A. De Kersaint-Gilly, C. Taverneau, A. Madoz, and R. Liberge
- Subjects
Gynecology ,medicine.medical_specialty ,Radiological and Ultrasound Technology ,business.industry ,medicine ,Radiology, Nuclear Medicine and imaging ,Neurology (clinical) ,business ,Endovascular therapy - Abstract
Resume Les fistules arterioveineuses vertebrovertebrales (F.A.V.V.) sont une pathologie vasculaire rare, decouverte de facon fortuite ou lors de l’exploration d’acouphenes pulsatiles, d’un souffle cervical, d’une pathologie ischemique du territoire vertebrobasilaire. Elles peuvent etre spontanees ou, plus souvent, post traumatiques. Notre serie comprend 8 patients âges de 20 a 77 ans, 4 femmes et 4 hommes (4 FVV post-traumatiques, 4 FVV spontanees) pris en charge sur une periode de 15 ans. Le bilan pre-therapeutique a comporte les examens suivants : echo-doppler (n = 4), IRM (n = 3) et surtout arteriographie (n = 8). 7 patients sur 8 ont beneficie d’un traitement realise avec succes par voie endovasculaire (5 occlusions par ballon, 1 occlusion par spire et 1 par manœuvre mecanique), sans complication ni recidive, a l’exception d’un cas. Nous confrontons nos resultats a ceux rapportes dans la litterature et proposons une mise au point sur cette pathologie et sa prise en charge therapeutique, laquelle s’est uniformisee a travers le developpement des techniques d’embolisation endovasculaire.
- Published
- 2006
- Full Text
- View/download PDF
13. Whole-lung torsion complicating double lung transplantation: CT features
- Author
-
R. Liberge, F Corne, Eric Frampas, and A. David
- Subjects
medicine.medical_specialty ,Lung ,Radiological and Ultrasound Technology ,business.industry ,medicine.medical_treatment ,Double Lung Transplantation ,Torsion Abnormality ,Torsion (gastropod) ,Postoperative complication ,General Medicine ,030204 cardiovascular system & hematology ,medicine.disease ,Cystic fibrosis ,030218 nuclear medicine & medical imaging ,03 medical and health sciences ,0302 clinical medicine ,medicine.anatomical_structure ,X ray computed ,medicine ,Lung transplantation ,Radiology, Nuclear Medicine and imaging ,Radiology ,business - Published
- 2016
- Full Text
- View/download PDF
14. Série nantaise de 30 patients traités par radiothérapie en conditions stéréotaxiques au NovalisTM pour un cancer bronchopulmonaire non à petites cellules de stade 1
- Author
-
Marc-André Mahé, S. Josset Gaudaire, C. Blay, Loïc Campion, R. Liberge, J. Jasnot, and F. Thillays
- Subjects
Oncology ,Radiology, Nuclear Medicine and imaging - Abstract
Objectifs La radiotherapie en conditions stereotaxiques pulmonaire s’est imposee par ses bons resultats en termes de controle local et de tolerance comme nouveau standard therapeutique chez les patients atteints d’un carcinome bronchique non a petites cellules de stade 1 inoperables ou refusant la chirurgie. Notre etude avait pour objectif d’efficacite et la tolerance des 30 premiers traitements delivres dans le centre Rene-Gauducheau depuis 2011. Patients et methodes Trente patients ont ete traites en 3 ans et demi, tous atteints d’un cancer classe T1 ou T2N0M0, avec un accelerateur Novalis™, apres insertion d’un repere fiduciel et une scanographie dosimetrique (quadridimensionnelle en respiration libre ou en apnee expiratoire). Le protocole d’irradiation comprenait principalement quatre seances de 12 Gy prescrits sur l’isodose peripherique. Resultats L’âge moyen des patients etait de 71 ans, 23 cancers etaient de stade Ia (T1N0M0) et sept de stade Ib ou IIa (T2N0M0). La dose delivree a 50 % (D50) du volume tumoral macroscopique (GTV) etait en moyenne de 62,4 Gy. Le volume tumoral macroscopique moyen etait de 9 cm3, le volume cible previsionnel (PTV) de 33,9 cm3, avec des marges de 3 a 9 mm. Le suivi median etait de 15,2 mois. Trois patients ont ete atteints d’une pneumopathie radique aigue de grade 3 (10 %). La scanographie a montre a 3 mois 13 lesions stables, 15 en reponse partielle, deux en reponse complete et aucune en progression. Le taux de controle local etait de 100 % au cours du suivi. La probabilite de survie globale etait de 89,7 % apres un suivi median de 24mois. En revanche, trois patients ont ete atteints d’une evolution metastatique. Conclusion L’analyse des resultats obtenus dans notre etude confirme la faisabilite et l’interet d’une telle technique, transformant des indications palliatives en traitement curatif. Les etudes a venir diront si cette technique peut s’inscrire comme traitement de premiere intention chez tous les patients atteints d’un carcinome bronchique non a petites cellules de stade 1.
- Published
- 2015
- Full Text
- View/download PDF
15. [Vertebrovertebral arteriovenous fistula diagnosis and treatment: report of 8 cases and review of the literature]
- Author
-
A, Madoz, H, Desal, E, Auffray-Calvier, J, Isnard, R, Liberge, C, Taverneau, and A, De Kersaint-Gilly
- Subjects
Adult ,Male ,Arteriovenous Fistula ,Humans ,Female ,Jugular Veins ,Middle Aged ,Vertebral Artery ,Aged - Abstract
Vertebrovertebral Arteriovenous Fistula (V.V.A.V.F.) is a relatively rare entity. It may be an incidental finding or be detected in patients presenting with pulsatile tinnitus, cervical bruit, or vertebro-basilar insufficiency. It can be spontaneous but it most frequently is post-traumatic in etiology. The authors report 8 patients, 4 women and 4 men aged between 20 to 77 years, with 4 post-traumatic V.V.A.V.F. and 4 spontaneous V.V.A.V.F. that were seen over a 15 year period. Imaging work-up included Doppler US (n=4), MRI 9n=3) and angiography (n=8). Seven of 8 patients were treated successfully using an endovascular technique (5 with balloon occlusion, 1 with coil embolization and 1 using a mechanical maneuver), without complication or recurrence, except in one case. We compare our results with published reports from the literature and review the underlying pathology and management strategies of V.V.A.V.F.
- Published
- 2007
16. Pneumopathie interstitielle liée à EBV : efficacité du rituximab
- Author
-
S. Dirou, C. Kandel-Aznar, J. Morin, J. Delaunay, F. Corne, François-Xavier Blanc, Christine Sagan, M. Illiaquer, A. Delbove, and R. Liberge
- Subjects
Pulmonary and Respiratory Medicine - Abstract
Mme H., 66 ans, a pour antecedent une maladie de Waldenstrom traitee par chimiotherapie puis allogreffe de mœlle osseuse apparentee en 2005. Elle est hospitalisee pour dyspnee febrile subaigue, toux et alteration de l’etat general persistant malgre deux lignes d’antibiotherapie. L’examen physique retrouvait une detresse respiratoire aigue avec crepitants bilateraux sans signes d’insuffisance cardiaque. Le rapport PaO2/FiO2 (Optiflow®, FiO2 60 %) etait a 108. On notait un syndrome inflammatoire avec une CRP a 228 mg/L, et un bilan immun negatif. La TDM thoracique objectivait un verre depoli diffus bilateral a predominance sous pleurale, et une lame d’epanchement pleural bilateral, sans lesion kystique ni adenopathie. Le lavage broncho-alveolaire retrouvait 80 % de lymphocytes mononucleosiques dont 33 % de plasmocytes polyclonaux. Une PCR EBV revenait positive a 4,9 log dans le lavage versus 2,9 log dans le sang. Ces elements ont permis de poser le diagnostic de pneumopathie interstitielle a EBV associee a une phase precoce de syndrome lympho-proliferatif post-transplantation (SPLT). L’evolution a ete favorable apres traitement anti-infectieux large et l’association corticoides-rituximab. Le SPLT, decrit en 1969, regroupe les hyperplasies post-transplantation d’organes solides et de mœlle osseuse. La phase initiale d’hyperplasie polyclonale peut evoluer vers une transformation monoclonale maligne. L’EBV est un facteur de mauvais pronostic associe au SPLT. L’atteinte pulmonaire se caracterise par une pneumopathie interstitielle avec verre depoli predominant. L’originalite de ce cas repose sur l’evolution favorable sous rituximab, puisque le pronostic est sombre, avec un deces dans pres de 100 % des cas dans la litterature.
- Published
- 2015
- Full Text
- View/download PDF
17. Traitement endobronchique d’une tumeur carcinoïde
- Author
-
M. Valette, Christine Sagan, R. Liberge, L. Cellerin, A. Chene, and Antoine Magnan
- Subjects
Pulmonary and Respiratory Medicine ,business.industry ,Medicine ,business - Published
- 2013
- Full Text
- View/download PDF
18. Hémoptysie au cours d’une grossesse : révélation d’une malformation…
- Author
-
R. Liberge, F. Calo-Lintz, S. Dirou, P.-L. Alexandre, Antoine Magnan, and Z. Cahouch
- Subjects
Pulmonary and Respiratory Medicine - Published
- 2012
- Full Text
- View/download PDF
19. Valeur sémiologique d’une lombalgie inaugurale d’une thrombose veineuse profonde proximale : rechercher un obstacle du carrefour ilio-cave
- Author
-
R. Liberge, Pierre Pottier, L. Khatchatourian, M. Hello, Bernard Planchon, J. Connault, and A. Guillet
- Subjects
Gastroenterology ,Internal Medicine - Published
- 2012
- Full Text
- View/download PDF
20. ORL-WP-1 Imagerie des formations kystiques congenitales cervicales
- Author
-
F. Léauté, E. Mourrain-Langlois, Benoît Dupas, A. Madoz, R. Liberge, Eric Frampas, and M. Gayet-Delacroix
- Subjects
Radiological and Ultrasound Technology ,Radiology, Nuclear Medicine and imaging - Abstract
Objectifs pedagogiques Savoir identifier les differentes formations kystiques cervicales congenitales rencontrees dans la pratique radiologique courante. Connaitre les modes de presentation clinique, les complications, les diagnostics differentiels et les pieges semeiologiques. Messages a retenir Les formations kystiques congenitales cervicales sont de decouverte fortuite ou diagnostiquees lors de complications. Le diagnostic radiologique requiert une bonne connaissance de l’embryogenese et de l’anatomie cervicale. Le scanner et l’IRM apportent les informations essentielles concernant la localisation des kystes.
- Published
- 2007
- Full Text
- View/download PDF
21. 260 Mésothéliome pleural malin : capacité de la tomodensitométrie et de l’imagerie par résonance magnétique à définir l’extension
- Author
-
Christine Sagan, S. Trogrlic, S. Bommart, C. Périgaud, J. Isnard, L. Cellerin, and R. Liberge
- Subjects
Pulmonary and Respiratory Medicine - Published
- 2007
- Full Text
- View/download PDF
22. THO16 Bilan IRM pre-operatoire du mesotheliome pleural malin. A propos de 23 cas
- Author
-
C. Sagan, S. Bommart, L. Cellerin, S. Trogrlic, A. Madoz, R. Liberge, and Benoît Dupas
- Subjects
Radiological and Ultrasound Technology ,Radiology, Nuclear Medicine and imaging - Abstract
Objectifs Evaluer la precision diagnostique du bilan radiologique preoperatoire du mesotheliome pleural malin (MPM). Materiels et methodes Etude retrospective concernant 23 patients porteurs d’un MPM de type epithelioide ou mixte. Tous ces patients ont beneficie d’une IRM thoracique, avant d’etre operes par pleuro-pneumonectomie extrapleurale suivi d’une irradiation complementaire. Les items suivants ont ete evalues : atteinte de la plevre parietale, de la plevre viscerale, du diaphragme, du mediastin, de la paroi, presence de metastases abdominales ou cerebrales. Resultats L’importance de l’atteinte tumorale a ete correctement appreciee dans 10 cas sur 23 : elle a ete sous-estimee dans 12 cas, elle a ete surestimee dans un seul cas. Ces sous-estimations sont essentiellement dues a une atteinte meme minime de la graisse mediastinale en regard d’un epaississement de la plevre mediastinale. L’atteinte ganglionnaire a ete correctement estimee dans 16 cas sur 23, dans tous les autres cas elle a ete sous-estimee. Aucune metastase n’a ete visualisee. Conclusion Le bilan IRM pre-operatoire du MPM apprecie la resecabilite tumorale de facon satisfaisante, il reste insuffisant dans l’atteinte mediastinale.
- Published
- 2006
- Full Text
- View/download PDF
23. Effects of continuous intravenous infusion of high concentrations of propylene glycol in the rat and dog
- Author
-
M. Grégoire, B. Héritier, R. Burnett, R. Liberge, N. Pickersqill, and K. Skydsgaard
- Subjects
chemistry.chemical_compound ,Chromatography ,chemistry ,Organic chemistry ,General Medicine ,Toxicology ,Polyvinyl alcohol - Published
- 1994
- Full Text
- View/download PDF
24. Artificial intelligence-driven volumetric CT outcome score in cystic fibrosis: longitudinal and multicenter validation with/without modulators treatment.
- Author
-
Hadj Bouzid AI, Bui S, Benlala I, Berger P, Hutt A, Liberge R, Habert P, Gaubert JY, Baque-Juston M, Morel B, Ferretti G, Denis de Senneville B, Laurent F, Macey J, and Dournes G
- Abstract
Objectives: Holistic segmentation of CT structural alterations with 3D deep learning has recently been described in cystic fibrosis (CF), allowing the measurement of normalized volumes of airway abnormalities (NOVAA-CT) as an automated quantitative outcome. Clinical validations are needed, including longitudinal and multicenter evaluations., Materials and Methods: The validation study was retrospective between 2010 and 2023. CF patients undergoing Elexacaftor/Tezacaftor/Ivacaftor (ETI) or corticosteroids for allergic broncho-pulmonary aspergillosis (ABPA) composed the monocenter ETI and ABPA groups, respectively. Patients from six geographically distinct institutions composed a multicenter external group. All patients had completed CT and pulmonary function test (PFT), with a second assessment at 1 year in case of ETI or ABPA treatment. NOVAA-CT quantified bronchiectasis, peribronchial thickening, bronchial mucus, bronchiolar mucus, collapse/consolidation, and their overall total abnormal volume (TAV). Two observers evaluated the visual Bhalla score., Results: A total of 139 CF patients (median age, 15 years [interquartile range: 13-25]) were evaluated. All correlations between NOVAA-CT to both PFT and Bhalla score were significant in the ETI (n = 60), ABPA (n = 20), and External groups (n = 59), such as the normalized TAV (ρ ≥ 0.76; p < 0.001). In both ETI and ABPA groups, there were significant longitudinal improvements in peribronchial thickening, bronchial mucus, bronchiolar mucus and collapse/consolidation (p ≤ 0.001). An additional reversibility in bronchiectasis volume was quantified with ETI (p < 0.001). Intraclass correlation coefficient of reproducibility was > 0.99., Conclusion: NOVAA-CT automated scoring demonstrates validity, reliability and responsiveness for monitoring CF severity over an entire lung and quantifies therapeutic effects on lung structure at CT, such as the volumetric reversibility of airway abnormalities with ETI., Clinical Relevance Statement: Normalized volume of airway abnormalities at CT automated 3D outcome enables objective, reproducible, and holistic monitoring of cystic fibrosis severity over an entire lung for management and endpoints during therapeutic trials., Key Points: Visual scoring methods lack sensitivity and reproducibility to assess longitudinal bronchial changes in cystic fibrosis (CF). AI-driven volumetric CT scoring correlates longitudinally to disease severity and reliably improves with Elexacaftor/Tezacaftor/Ivacaftor or corticosteroid treatments. AI-driven volumetric CT scoring enables reproducible monitoring of lung disease severity in CF and quantifies longitudinal structural therapeutic effects., (© 2024. The Author(s), under exclusive licence to European Society of Radiology.)
- Published
- 2024
- Full Text
- View/download PDF
25. Pneumothorax Incidence with Normal Saline Instillation for Sealing the Needle Track After Computed Tomography-Guided Percutaneous Lung Biopsy.
- Author
-
Bourgeais G, Frampas E, Liberge R, Nicolas A, Defrance C, Blanc FX, Coudol S, and Morla O
- Subjects
- Humans, Female, Male, Retrospective Studies, Middle Aged, Incidence, Aged, Biopsy, Needle adverse effects, Biopsy, Needle methods, Chest Tubes, Adult, Pneumothorax etiology, Pneumothorax prevention & control, Pneumothorax epidemiology, Tomography, X-Ray Computed methods, Saline Solution administration & dosage, Image-Guided Biopsy methods, Image-Guided Biopsy adverse effects, Lung diagnostic imaging, Lung pathology, Radiography, Interventional methods
- Abstract
Purpose: To determine whether instillation of normal saline solution for sealing the needle track reduces incidence of pneumothorax and chest tube placement after computed tomography-guided percutaneous lung biopsy., Materials and Methods: A total of 242 computed tomography-guided percutaneous lung biopsies performed at a single institution were retrospectively reviewed, including 93 biopsies in which the needle track was sealed by instillation of 3-5 ml of normal saline solution during needle withdrawal (water seal group) and 149 biopsies without sealing (control group). Patient and lesion characteristics, procedure-specific variables, pneumothorax and chest tube placement rates were recorded., Results: Baseline characteristics were comparable in both groups. There was a statistically significant decrease in the pneumothorax rate (19.4% [18/93] vs. 40.9% [61/149]; p < 0.001) and a numerically lower chest tube placement rate without significant reduction (4.3% [4/93] vs. 10.7% [16/149]; p = 0.126) with using normal saline instillation for sealing the needle track versus not using sealant material. Using a multiple logistic regression analysis, using normal saline instillation to seal the needle track, having a senior radiologist as operator of the procedure and putting patients in prone position were significantly associated with a decreased risk of pneumothorax. The presence of emphysema along the needle track was significantly associated with an increased risk of pneumothorax. No complication was observed due to normal saline injection., Conclusion: Normal saline solution instillation for sealing the needle track after computed tomography-guided percutaneous lung biopsy is a simple, low-cost and safe technique resulted in significantly decreased pneumothorax occurrence and a numerically lower chest tube placement rate, and might help to reduce both hospitalization risks and costs for the healthcare system. Level of evidence 3 Non-controlled retrospective cohort study., (© 2024. Springer Science+Business Media, LLC, part of Springer Nature and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE).)
- Published
- 2024
- Full Text
- View/download PDF
26. Chest tube placement incidence when using gelatin sponge torpedoes after pulmonary radiofrequency ablation.
- Author
-
Graveleau P, Frampas É, Perret C, Volpi S, Blanc FX, Goronflot T, and Liberge R
- Abstract
Purpose: To assess the efficacy of the gelatin torpedoes embolization technique after lung neoplastic lesions percutaneous radiofrequency ablation (PRFA) to reduce chest tube placement rate and hospital length of stay, and the safety of this embolization technique., Materials and Methods: A total of 114 PRFA of lung neoplastic lesions performed in two centers between January 2017 and December 2022 were retrospectively reviewed. Two groups were compared, with 42 PRFA with gelatin torpedoes embolization technique (gelatin group) and 72 procedures without (control group). Procedures were performed by one of seven interventional radiologists using LeVeen CoAccess™ probe. Multivariate analyses were performed to identify risk factors for chest tube placement and hospital length of stay., Results: There was a significantly lower chest tube placement rate in the gelatin group compared to the control group (3 [7.1 %] vs. 27 [37.5 %], p < 0,001). Multivariate analysis showed a significant association between chest tube placement and gelatin torpedoes embolization technique (OR: 0.09; 95 % CI: 0.02-0.32; p = 0.0006). No significant difference was found in hospital length of stay between the two groups. Multivariate analysis did not show a significant relationship between hospital length of stay and gelatin torpedoes embolization technique. No embolic complication occurred in the gelatin group., Conclusion: Gelatin torpedoes embolization technique after PRFA of lung neoplastic lesions resulted in significantly reduced chest tube placement rate in our patient population. No significant reduction in hospital length of stay was observed. No major complication occurred in the gelatin group., Competing Interests: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (© 2024 The Authors.)
- Published
- 2024
- Full Text
- View/download PDF
27. Detection and severity quantification of pulmonary embolism with 3D CT data using an automated deep learning-based artificial solution.
- Author
-
Djahnine A, Lazarus C, Lederlin M, Mulé S, Wiemker R, Si-Mohamed S, Jupin-Delevaux E, Nempont O, Skandarani Y, De Craene M, Goubalan S, Raynaud C, Belkouchi Y, Afia AB, Fabre C, Ferretti G, De Margerie C, Berge P, Liberge R, Elbaz N, Blain M, Brillet PY, Chassagnon G, Cadour F, Caramella C, Hajjam ME, Boussouar S, Hadchiti J, Fablet X, Khalil A, Talbot H, Luciani A, Lassau N, and Boussel L
- Subjects
- Humans, Tomography, X-Ray Computed methods, Heart Ventricles, Retrospective Studies, Deep Learning, Pulmonary Embolism diagnostic imaging, Thrombosis
- Abstract
Purpose: The purpose of this study was to propose a deep learning-based approach to detect pulmonary embolism and quantify its severity using the Qanadli score and the right-to-left ventricle diameter (RV/LV) ratio on three-dimensional (3D) computed tomography pulmonary angiography (CTPA) examinations with limited annotations., Materials and Methods: Using a database of 3D CTPA examinations of 1268 patients with image-level annotations, and two other public datasets of CTPA examinations from 91 (CAD-PE) and 35 (FUME-PE) patients with pixel-level annotations, a pipeline consisting of: (i), detecting blood clots; (ii), performing PE-positive versus negative classification; (iii), estimating the Qanadli score; and (iv), predicting RV/LV diameter ratio was followed. The method was evaluated on a test set including 378 patients. The performance of PE classification and severity quantification was quantitatively assessed using an area under the curve (AUC) analysis for PE classification and a coefficient of determination (R²) for the Qanadli score and the RV/LV diameter ratio., Results: Quantitative evaluation led to an overall AUC of 0.870 (95% confidence interval [CI]: 0.850-0.900) for PE classification task on the training set and an AUC of 0.852 (95% CI: 0.810-0.890) on the test set. Regression analysis yielded R² value of 0.717 (95% CI: 0.668-0.760) and of 0.723 (95% CI: 0.668-0.766) for the Qanadli score and the RV/LV diameter ratio estimation, respectively on the test set., Conclusion: This study shows the feasibility of utilizing AI-based assistance tools in detecting blood clots and estimating PE severity scores with 3D CTPA examinations. This is achieved by leveraging blood clots and cardiac segmentations. Further studies are needed to assess the effectiveness of these tools in clinical practice., Competing Interests: Disclosure of Interests The authors declare that they have no competing interest., (Copyright © 2023 Société française de radiologie. Published by Elsevier Masson SAS. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
28. Detection and quantification of pulmonary embolism with artificial intelligence: The SFR 2022 artificial intelligence data challenge.
- Author
-
Belkouchi Y, Lederlin M, Ben Afia A, Fabre C, Ferretti G, De Margerie C, Berge P, Liberge R, Elbaz N, Blain M, Brillet PY, Chassagnon G, Cadour F, Caramella C, Hajjam ME, Boussouar S, Hadchiti J, Fablet X, Khalil A, Luciani A, Cotten A, Meder JF, Talbot H, and Lassau N
- Subjects
- Humans, Artificial Intelligence, Lung, ROC Curve, Retrospective Studies, Tomography, X-Ray Computed methods, Pulmonary Embolism diagnostic imaging
- Abstract
Purpose: In 2022, the French Society of Radiology together with the French Society of Thoracic Imaging and CentraleSupelec organized their 13th data challenge. The aim was to aid in the diagnosis of pulmonary embolism, by identifying the presence of pulmonary embolism and by estimating the ratio between right and left ventricular (RV/LV) diameters, and an arterial obstruction index (Qanadli's score) using artificial intelligence., Materials and Methods: The data challenge was composed of three tasks: the detection of pulmonary embolism, the RV/LV diameter ratio, and Qanadli's score. Sixteen centers all over France participated in the inclusion of the cases. A health data hosting certified web platform was established to facilitate the inclusion process of the anonymized CT examinations in compliance with general data protection regulation. CT pulmonary angiography images were collected. Each center provided the CT examinations with their annotations. A randomization process was established to pool the scans from different centers. Each team was required to have at least a radiologist, a data scientist, and an engineer. Data were provided in three batches to the teams, two for training and one for evaluation. The evaluation of the results was determined to rank the participants on the three tasks., Results: A total of 1268 CT examinations were collected from the 16 centers following the inclusion criteria. The dataset was split into three batches of 310, 580 and 378 C T examinations provided to the participants respectively on September 5, 2022, October 7, 2022 and October 9, 2022. Seventy percent of the data from each center were used for training, and 30% for the evaluation. Seven teams with a total of 48 participants including data scientists, researchers, radiologists and engineering students were registered for participation. The metrics chosen for evaluation included areas under receiver operating characteristic curves, specificity and sensitivity for the classification task, and the coefficient of determination r
2 for the regression tasks. The winning team achieved an overall score of 0.784., Conclusion: This multicenter study suggests that the use of artificial intelligence for the diagnosis of pulmonary embolism is possible on real data. Moreover, providing quantitative measures is mandatory for the interpretability of the results, and is of great aid to the radiologists especially in emergency settings., Competing Interests: Disclosure of Interests The authors declare that they have no known competing financial or personal relationships that could be viewed as influencing the work reported in this paper., (Copyright © 2023 Société française de radiologie. Published by Elsevier Masson SAS. All rights reserved.)- Published
- 2023
- Full Text
- View/download PDF
29. Generating High-Resolution Synthetic CT from Lung MRI with Ultrashort Echo Times: Initial Evaluation in Cystic Fibrosis.
- Author
-
Longuefosse A, Raoult J, Benlala I, Denis de Senneville B, Benkert T, Macey J, Bui S, Berger P, Ferretti G, Gaubert JY, Liberge R, Hutt A, Morel B, Laurent F, Baldacci F, and Dournes G
- Subjects
- Adolescent, Adult, Humans, Male, Young Adult, Lung diagnostic imaging, Magnetic Resonance Imaging methods, Retrospective Studies, Tomography, X-Ray Computed methods, Female, Child, Cystic Fibrosis diagnostic imaging
- Abstract
Background Lung MRI with ultrashort echo times (UTEs) enables high-resolution and radiation-free morphologic imaging; however, its image quality is still lower than that of CT. Purpose To assess the image quality and clinical applicability of synthetic CT images generated from UTE MRI by a generative adversarial network (GAN). Materials and Methods This retrospective study included patients with cystic fibrosis (CF) who underwent both UTE MRI and CT on the same day at one of six institutions between January 2018 and December 2022. The two-dimensional GAN algorithm was trained using paired MRI and CT sections and tested, along with an external data set. Image quality was assessed quantitatively by measuring apparent contrast-to-noise ratio, apparent signal-to-noise ratio, and overall noise and qualitatively by using visual scores for features including artifacts. Two readers evaluated CF-related structural abnormalities and used them to determine clinical Bhalla scores. Results The training, test, and external data sets comprised 82 patients with CF (mean age, 21 years ± 11 [SD]; 42 male), 28 patients (mean age, 18 years ± 11; 16 male), and 46 patients (mean age, 20 years ± 11; 24 male), respectively. In the test data set, the contrast-to-noise ratio of synthetic CT images (median, 303 [IQR, 221-382]) was higher than that of UTE MRI scans (median, 9.3 [IQR, 6.6-35]; P < .001). The median signal-to-noise ratio was similar between synthetic and real CT (88 [IQR, 84-92] vs 88 [IQR, 86-91]; P = .96). Synthetic CT had a lower noise level than real CT (median score, 26 [IQR, 22-30] vs 42 [IQR, 32-50]; P < .001) and the lowest level of artifacts (median score, 0 [IQR, 0-0]; P < .001). The concordance between Bhalla scores for synthetic and real CT images was almost perfect (intraclass correlation coefficient, ≥0.92). Conclusion Synthetic CT images showed almost perfect concordance with real CT images for the depiction of CF-related pulmonary alterations and had better image quality than UTE MRI. Clinical trial registration no. NCT03357562 © RSNA, 2023 Supplemental material is available for this article. See also the editorial by Schiebler and Glide-Hurst in this issue.
- Published
- 2023
- Full Text
- View/download PDF
30. [Transbronchial lung cryobiopsy in interstitial lung diseases].
- Author
-
Menigoz C, Dirou S, Sagan C, Corne F, Moui A, Defrance C, Liberge R, Morla O, Patarin V, Nicolas A, Kandel-Aznar C, Lacoste P, Clarke JP, Cavailles A, Cellerin L, and Blanc FX
- Subjects
- Humans, Biopsy, Histological Techniques, Lung, Lung Diseases, Interstitial, Pneumothorax
- Abstract
In some cases of interstitial lung disease (ILD), clinical and biological findings associated with CT scan pattern during multidisciplinary discussion (MDD) fail to yield a confident diagnosis. In these cases, histology may be necessary. Transbronchial lung cryobiopsy (TBLC) is a bronchoscopic procedure that has been developed in recent years and currently contributes to diagnostic work-up in patients with ILD. TBLC provides tissue samples for histological analysis with an acceptable risk of complications, consisting mainly in pneumothorax or bleeding. In addition to higher diagnostic yield than conventional forceps biopsies, the procedure shows a better safety profile than surgical biopsies. The indication to perform TBLC is decided during a 1st MDD and during a 2nd MDD, results can provide a diagnostic yield approximating 80%. TBLC appears to be an attractive, minimally invasive technique to be proposed as a first-line procedure in selected patients in experienced centers, while surgical lung biopsy may be considered as a second-line solution., (Copyright © 2023 SPLF. Published by Elsevier Masson SAS. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
31. Safety of High-Frequency Jet Ventilation During Image-Guided Thermal Ablation Procedures.
- Author
-
Trochu T, Desfriches-Doria N, Grillot N, Feuillet F, Lair D, Liberge R, Douane F, Dumont R, and David A
- Subjects
- Adult, Humans, Respiration, High-Frequency Jet Ventilation methods, Ablation Techniques
- Abstract
Rationale and Objective: Percutaneous thermal ablative technique is a common radiological procedure for malignant lesions treatment. Controlled assisted ventilation during general anesthesia is the usual mode of ventilation, but high-frequency jet ventilation (HFJV) can be a helpful alternative for the operator. The objective was to evaluate the safety of HFJV during thermal ablation procedures., Materials and Methods: This monocentric prospective analysis included adult patients undergoing percutaneous thermal ablation procedures for abdominal tumor performed under HFJV. Procedures with a transpulmonary path were excluded. The primary outcome was the incidence of respiratory complications. Secondary outcomes included gas exchange modifications (hypercapnia, hypoxemia, pulmonary atelectasis) and the incidence of barotrauma., Results: Sixty patients were included during the study period. The mean duration time was 88 min. All procedures went according to the protocol and there was no respiratory complication. There was no barotrauma event. Three patients had an exhaled capnia above 45 mmHg at the end of the procedure which normalized within 10 min of conventional ventilation., Conclusion: HFJV during thermal ablation procedures is safe regarding gas exchange and barotrauma. This technique could be an interesting alternative to conventional ventilation during image-guided thermal ablation procedures. Clinical Trials database This study was registered in Clinical Trials database (NCT04209608)., (© 2023. Springer Science+Business Media, LLC, part of Springer Nature and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE).)
- Published
- 2023
- Full Text
- View/download PDF
32. [Immune-related pneumonitis: A differential diagnosis of SARS-CoV-2 pneumonia].
- Author
-
Nigen B, Chéné AL, Liberge R, Sagan C, and Blanc FX
- Subjects
- Adrenal Cortex Hormones therapeutic use, COVID-19 Testing, Diagnosis, Differential, Humans, SARS-CoV-2, COVID-19 diagnosis, Neoplasms therapy, Pneumonia diagnosis
- Abstract
Introduction: Immune checkpoint inhibitors have revolutionized the management of many cancers and achieved efficacy and durable response for some patients, including those with advanced cancers. However, immunotherapy is associated with side effects caused by the infiltration of immune cells into normal tissues, which can lead to disproportionate dysimmune reactions. While mostly of moderate intensity, these side effects can affect any organ, including the lung, the site of occasionally life-threatening interstitial lung disease. Their presentation can be similar to that of infectious pneumonia (COVID-19)., Observations: We report the cases of 3 patients who presented between March and May 2020 with severe pulmonary toxicities secondary to immunotherapy, which led to with an initial hypothesis of SARS-CoV-2 pneumonia. After extensive investigations, the diagnosis of pulmonary toxicity to immunotherapy was given, and the clinical and radiological course following the initiation of corticosteroid therapy was favorable., Conclusion: Pulmonary toxicity secondary to immunotherapy remains a rare but potentially life-threatening side effect. The diagnostic approach requires the elimination of several differential diagnoses (infectious process, tumor progression, other etiologies of interstitial lung disease). This adverse event is reversible and evolution after initiation of corticosteroid therapy is usually favorable., (Copyright © 2022 SPLF. Published by Elsevier Masson SAS. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
33. Immune alveolitis in interstitial lung disease: an attractive cytological profile in immunocompromised patients.
- Author
-
Moui A, Dirou S, Sagan C, Liberge R, Defrance C, Arrigoni PP, Morla O, Kandel-Aznar C, Cellerin L, Cavailles A, Eschapasse E, Morio F, Gourraud PA, Goronflot T, Tissot A, and Blanc FX
- Subjects
- Adult, Aged, Female, Humans, Lung Diseases, Interstitial pathology, Male, Middle Aged, Retrospective Studies, Immunocompromised Host, Lung Diseases, Interstitial complications, Lung Diseases, Interstitial immunology, Pulmonary Alveoli pathology
- Abstract
Background: Bronchoalveolar lavage (BAL) is a major diagnostic tool in interstitial lung disease (ILD). Its use remains largely quantitative, usually focused on cell differential ratio. However, cellular morphological features provide additional valuable information. The significance of the "immune alveolitis" cytological profile, characterized by lymphocytic alveolitis with activated lymphocytes and macrophages in epithelioid transformation or foamy macrophages desquamating in cohesive clusters with lymphocytes, remains unknown in ILD. Our objective was to describe patients' characteristics and diagnoses associated with an immune alveolitis profile in undiagnosed ILD., Methods: We performed a monocentric retrospective observational study. Eligible patients were adults undergoing diagnostic exploration for ILD and whose BAL fluid displayed an immune alveolitis profile. For each patient, we collected clinical, radiological and biological findings as well as the final etiology of ILD., Results: Between January 2012 and December 2018, 249 patients were included. Mean age was 57 ± 16 years, 140 patients (56%) were men, and 65% of patients were immunocompromised. The main etiological diagnosis was Pneumocystis pneumonia (PCP) (24%), followed by drug-induced lung disease (DILD) (20%), viral pneumonia (14%) and hypersensitivity pneumonitis (HP) (10%). All PCP were diagnosed in immunocompromised patients while HP was found in only 8% of this subgroup. DILD and viral pneumonia were also commonly diagnosed in immunocompromised patients (94% and 80%, respectively)., Conclusion: Our study highlights the additional value of BAL qualitative description in ILD. We suggest incorporating the immune alveolitis profile for the diagnosis and management of ILD, especially in immunocompromised patients, since it guides towards specific diagnoses., (© 2022. The Author(s).)
- Published
- 2022
- Full Text
- View/download PDF
34. Evaluation of the Post-COVID-19 Functional Status (PCFS) Scale in a cohort of patients recovering from hypoxemic SARS-CoV-2 pneumonia.
- Author
-
Benkalfate N, Eschapasse E, Georges T, Leblanc C, Dirou S, Melscoet L, Chéné AL, Horeau-Langlard D, Bry C, Chambellan A, Nicolas A, Claire D, Liberge R, Karakachoff M, Hardouin JB, Blanc FX, and Lemarchand P
- Subjects
- Functional Status, Humans, Quality of Life, SARS-CoV-2, COVID-19 complications, Pneumonia diagnosis
- Abstract
Introduction: COVID-19 sequelae are numerous and multisystemic, and how to evaluate those symptomatic patients is a timely issue. Klok et al proposed the Post-COVID-19 Functional Status (PCFS) Scale as an easy tool to evaluate limitations related to persistent symptoms. Our aim was to analyse PCFS Scale ability to detect functional limitations and its correlation with quality of life in a cohort of patients, 2-9 months after hospitalisation for COVID-19 hypoxemic pneumonia., Methods: PCFS Scale was evaluated in 121 patients together with quality of life and dyspnoea questionnaires, pulmonary function tests and CT scans., Results: We observed a high correlation with multiple questionnaires (Short Form-36, Hospital Anxiety and Depression Scale, modified Medical Research Council, end Borg Six-Minute Walk Test), making the PCFS Scale a quick and global tool to evaluate functional limitations related to various persistent symptoms following COVID-19 pneumonia., Discussion: The PCFS Scale seems to be a suitable instrument to screen for patients who will require careful follow-up after COVID-19 hypoxemic pneumonia even in the absence of pulmonary sequelae., Competing Interests: Competing interests: None declared., (© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.)
- Published
- 2022
- Full Text
- View/download PDF
35. Percutaneous thermal ablation of lung metastases from thyroid carcinomas. A retrospective multicenter study of 107 nodules. On behalf of the TUTHYREF network.
- Author
-
Bonichon F, de Baere T, Berdelou A, Leboulleux S, Giraudet AL, Cuinet M, Drui D, Liberge R, Kelly A, Tenenbaum F, Legmann P, Do Cao C, Leenhardt L, Toubeau M, Godbert Y, and Palussière J
- Subjects
- Humans, Microwaves, Retrospective Studies, Survival Rate, Treatment Outcome, Catheter Ablation, Lung Neoplasms surgery, Thyroid Neoplasms surgery
- Abstract
Purpose: To determine efficacy and safety of thermal ablation (TA) for the local treatment of lung metastases of thyroid cancer., Methods: We retrospectively studied 47 patients from 10 centers treated by TA (radiofrequency, microwaves, and cryoablation) over 10 years. The endpoints were overall survival (OS), local efficacy, complications (CTCAE classification), and factors associated with survival. OS curves after first TA were built using the Kaplan-Meier method and compared with the log-rank test., Results: A total of 107 lung metastases during 75 sessions were treated by radiofrequency (n = 56), microwaves (n = 9), and cryoablation (n = 10). Median follow-up time after TA was 5.2 years (0.2-13.3). OS was 93% at 2 years (95% confidence interval (CI): 86-94) and 79% at 3 years (95% CI: 66-91). On univariate and multivariate analysis with a Cox model, histology was the only significant factor for OS. OS at 3 years was 94% for follicular, oncocytic, or papillary follicular variant carcinomas, compared to 59% for papillary, medullary, insular or anaplastic carcinomas (P = 0.0001). The local control rate was 98.1% at 1 year and 94.8% at 2, 3, 4, and 5 years. Morbidity was low with no major complications (grade 4 and 5 CTCAE) and no complications in 29 of 75 sessions (38.7%)., Conclusions: TA is a useful, safe and effective option for local treatment of lung metastases from thyroid carcinoma. Prolonged OS was obtained, especially for lung metastases from follicular, oncocytic, or papillary follicular variant carcinomas. Achieving disease control with TA delays the need for systemic treatment.
- Published
- 2021
- Full Text
- View/download PDF
36. Incidental findings suggestive of COVID-19 in asymptomatic cancer patients undergoing 18F-FDG PET/CT in a low prevalence region.
- Author
-
Pallardy A, Rousseau C, Labbe C, Liberge R, Bodet-Milin C, Kraeber-Bodere F, and Fleury V
- Subjects
- Aged, COVID-19 complications, COVID-19 diagnostic imaging, Female, Fluorodeoxyglucose F18, Humans, Lung diagnostic imaging, Male, Middle Aged, Neoplasms diagnostic imaging, Prevalence, Radiopharmaceuticals, Asymptomatic Infections epidemiology, COVID-19 epidemiology, Incidental Findings, Neoplasms complications, Positron Emission Tomography Computed Tomography
- Abstract
Purpose: To assess the rate and pattern of incidental interstitial lung abnormalities suggestive of COVID-19 on 18F-FDG PET/CT in asymptomatic cancer patients during the period of active COVID-19 circulation between March and April 2020 in a geographic area of low prevalence of the virus., Methods: 1396 18F-FDG PET/CT performed between January 1, 2020, and February 21, 2020, and between March 16, 2020, and April 17, 2020 for routine oncological indication were retrospectively analyzed. No patients had symptoms suggestive of COVID-19 at the time of the 18F-FDG PET/CT. Incidental interstitial pneumonias suggestive of COVID-19 were identified, and the 18F-FDG PET/CT patterns were described. We compared the incidence of these lesions in the pre-COVID and pandemic phases., Results: We observed a 1.6% increase in interstitial lung abnormalities during the period of COVID-19 circulation. All had < 50% lung involvement. We describe a case series with typical and atypical interstitial pneumonias suggestive of COVID-19 as unilateral or bilateral with ground-glass opacity, consolidation, or crazy-paving patterns., Conclusion: The relatively low increase in incidental findings suggestive of COVID-19 infection on 18F-FDG PET/CT in asymptomatic cancer patients was in accordance with the low COVID-19 transmission in our geographic region. Nevertheless, nuclear medicine physicians should familiarize themselves with typical and atypical 18F-FDG PET/CT patterns suggestive of COVID-19 pneumonia and initiate appropriate intervention where necessary.
- Published
- 2021
- Full Text
- View/download PDF
37. [An hereditary hemorrhagic telangiectasia of late revealed by a cerebral venous thrombosis: A case report].
- Author
-
Constant Dit Beaufils P, De Gaalon S, Espitia O, Ploton G, Mercier S, Liberge R, and Connault J
- Subjects
- Anticoagulants therapeutic use, Arteriovenous Fistula diagnosis, Arteriovenous Fistula drug therapy, Arteriovenous Fistula etiology, Delayed Diagnosis, Diagnosis, Differential, Humans, Intracranial Thrombosis diagnosis, Intracranial Thrombosis drug therapy, Late Onset Disorders, Magnetic Resonance Imaging, Male, Middle Aged, Pulmonary Artery abnormalities, Pulmonary Embolism diagnosis, Pulmonary Embolism drug therapy, Pulmonary Embolism etiology, Pulmonary Veins abnormalities, Rivaroxaban therapeutic use, Telangiectasia, Hereditary Hemorrhagic complications, Telangiectasia, Hereditary Hemorrhagic drug therapy, Venous Thrombosis diagnosis, Venous Thrombosis drug therapy, Intracranial Thrombosis etiology, Telangiectasia, Hereditary Hemorrhagic diagnosis, Venous Thrombosis etiology
- Abstract
Introduction: Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disease characterized by the triad of nose bleeding, telangiectasia and familial heredity., Case Report: We report the case of a patient who had idiopathic venous cerebral thrombosis complicated by a cerebral infarction treated with warfarin. In the context of a psoas hematoma by warfarine overdose and immobilization, the patient had deep vein thrombosis of the left lower limb with pulmonary embolism revealing a pulmonary arteriovenous malformation. After a reexamination, the patient clinical phenotype of HHT was confirmed genetically. The patient was treated with rivaroxaban allowing clinical improvement and partial recanalization of all thrombosis after six months. Thrombotic overisk has already been studied in HHT patients but the use of anticoagulants is at higher risk in these patients. However this patient experienced no adverse event with rivaroxaban., Conclusion: This is the first case described of cerebral venous thrombosis treated with rivaroxaban revealing an HHT., (Copyright © 2020. Published by Elsevier Masson SAS.)
- Published
- 2020
- Full Text
- View/download PDF
38. Pneumocystis pneumonia after lung transplantation: A retrospective multicenter study.
- Author
-
Delbove A, Alami H, Tissot A, Dégot T, Liberge R, Mornex JF, Murris M, Dromer C, Claustre J, Boussaud V, Brugière O, Le Pavec J, Nicolas A, Danner-Boucher I, Magnan A, Roussel JC, and Blanc FX
- Subjects
- Adult, Aged, Cohort Studies, Female, France, Humans, Male, Middle Aged, Multicenter Studies as Topic, Retrospective Studies, Time Factors, Trimethoprim, Sulfamethoxazole Drug Combination therapeutic use, Lung Transplantation adverse effects, Lung Transplantation mortality, Pneumonia, Pneumocystis diagnosis, Pneumonia, Pneumocystis drug therapy, Pneumonia, Pneumocystis epidemiology, Pneumonia, Pneumocystis prevention & control, Postoperative Complications diagnosis, Postoperative Complications drug therapy, Postoperative Complications epidemiology, Postoperative Complications prevention & control
- Abstract
Background: Lung transplantation (LT) is an identified risk factor for Pneumocystis pneumonia (PCP). However, PCP management and outcomes remain poorly described in LT recipients and PCP incidence is rarely documented in this population., Methods: PCP episodes that occurred in 9 French LT centers between January 2010 and October 2017 were included in this analysis. PCP was defined as compatible clinical and radiologic findings associated with fungal identification., Results: Forty-seven PCP were included. The annual incidence rate of PCP was 2.7/1000 patients/year. Patients had a mean age of 53 ± 14 years. Median time from LT was 2.4 ± 3.0 years. Sixty-five percent of patients were not on prophylaxis at the time of PCP while all patients were receiving steroids at the time of PCP. Diagnosis was obtained by bronchoalveolar lavage in 91% (direct examination: 47%, PCR: 62%). The majority of patients were treated with trimethoprim-sulfamethoxazole (78%). Fifty-five percent of patients were hospitalized in ICU for organ failure (for which non-invasive ventilation was used for 21% and mechanical ventilation for 23%). Mortality rate was 15% at day 28 and reached 23% at day 90. Mortality was associated with decreased FEV1, everolimus treatment, Pseudomonas aeruginosa coinfection, fungal coinfection (especially Aspergillus sp.), mechanical ventilation and vasopressors. PCP primary prophylaxis, steroid modification during PCP and the number of immunosuppressive molecules were not associated with mortality., Conclusion: PCP is associated with a high mortality in LT. Our data suggest the need for a lifetime PCP prophylaxis in LT recipients. The benefit of adjuvant steroids remains unclear., Competing Interests: Declaration of competing interest T. Degot reports personal fees from Boehringer Ingelheim France, with no links to the submitted work; other authors have nothing to declare. No funding source has to be declared., (Copyright © 2020 Elsevier Ltd. All rights reserved.)
- Published
- 2020
- Full Text
- View/download PDF
39. Ultrasonographic guidance for portal vein access during transjugular intrahepatic portosystemic shunt (TIPS) placement.
- Author
-
David A, Liberge R, Meyer J, Morla O, Leaute F, Archambeaud I, Gournay J, Trewick D, Frampas E, Perret C, and Douane F
- Subjects
- Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Retrospective Studies, Young Adult, Portal Vein diagnostic imaging, Portasystemic Shunt, Transjugular Intrahepatic methods, Punctures, Ultrasonography, Interventional
- Abstract
Purpose: The purpose of our study was to retrospectively assess the safety and efficacy of percutaneous real-time ultrasound guidance for portal vein puncture during transjugular intrahepatic portosystemic shunt (TIPS) placement., Materials and Methods: Between January 2011 and November 2018, procedure details and outcome were retrospectively analyzed for 224 patients who underwent TIPS placement using real-time ultrasound guidance for portal vein puncture. There were 175 men and 49 women with a mean age of 52.7±10.6 (SD) years (range: 22-82 years). For each procedure, technical success, primary ultrasound guidance success, portosystemic pressure gradient, duration of the intervention, procedural complications, radiation exposure, mortality and morbidity rates at day 30 post-procedure were recorded for data analysis., Results: Technical success rate was 100.0% with a success rate of the primary ultrasound guidance of 97.8% (219/224; 95% CI: 95.8-99.7). Mean duration of the procedure was 86.2±41.7 (SD) min (range: 22.0-267.0min). Mean dose-area product was 62.0±50.2 (SD) Gy.cm
2 (range: 3.7-306.5Gy.cm2 ). Twelve complications (12/224; 5.4%) occurred in ten patients during TIPS procedures including 8 arterial punctures (3.6%) and 4 biliary punctures (1.8%). Four complications (4/224; 1.8%) were clinically significant. Mortality rate at day 30 after the procedure was 9.8% (22/224), without any patient dying from technical complications., Conclusion: Real-time ultrasound guidance is a safe technique to assist in the creation of TIPS and may allow for lower radiation exposure., (Copyright © 2019 Société française de radiologie. Published by Elsevier Masson SAS. All rights reserved.)- Published
- 2019
- Full Text
- View/download PDF
40. Bronchiectasis is highly prevalent in anti-MPO ANCA-associated vasculitis and is associated with a distinct disease presentation.
- Author
-
Néel A, Espitia-Thibault A, Arrigoni PP, Volteau C, Rimbert M, Masseau A, Agard C, Fakhouri F, Liberge R, and Hamidou M
- Subjects
- Aged, Antibodies, Antineutrophil Cytoplasmic immunology, Bronchiectasis diagnostic imaging, Bronchiectasis immunology, Comorbidity, Female, Granulomatosis with Polyangiitis diagnostic imaging, Granulomatosis with Polyangiitis immunology, Humans, Male, Microscopic Polyangiitis diagnostic imaging, Microscopic Polyangiitis immunology, Middle Aged, Prevalence, Retrospective Studies, Sex Factors, Bronchiectasis epidemiology, Granulomatosis with Polyangiitis epidemiology, Lung diagnostic imaging, Microscopic Polyangiitis epidemiology, Peroxidase immunology
- Abstract
Objectives: To assess the prevalence of bronchiectasis in a Western cohort with ANCA-positive granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA) and its correlations with disease presentation and outcome., Methods: Retrospective study of ANCA-associated vasculitis (AAV) patients followed at Nantes University Hospital (2005-2015). Clinical, biological, and follow-up data were collected through chart review. Two experienced radiologists blinded to the clinical data interpreted chest high-resolution CTs according to the Feischner Society criteria., Results: Fifty-eight patients were included: 30 had MPA (51.7%) and 28 had GPA (48.3%). The median age at AAV diagnosis was 65.5 years. Anti-MPO-ANCA and anti-PR3-ANCA were present in 39 (67.2%) and 19 (32.8%) patients, respectively. Overall, bronchiectasis was found in 22 patients (37.9%), all of whom had anti-MPO ANCA. In multivariate analysis, bronchiectasis was independently associated with anti-MPO-ANCA, female gender and age at AAV diagnosis. Furthermore, anti-MPO ANCA patients with bronchiectasis had more frequent peripheral nerve involvement (54.5 vs. 17.6%, p = 0.019) and less frequent renal involvement than those without bronchiectasis (40.9% vs. 82.3%, p = 0.009). Disease course, survival and risk of severe pulmonary infection were similar in patients with and without bronchiectasis on chest CT., Conclusions: This study shows that bronchiectasis is a highly prevalent pre-existing respiratory condition in Caucasian patients with anti-MPO AAV. This subset of patients exhibits a distinct presentation. Further studies are needed to confirm these findings and clarify the clinical implications of this association. Whether the respiratory tract could be the site of initiation of anti-MPO auto-immunity remains to be investigated., (Copyright © 2017 Elsevier Inc. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
41. CT-guided direct percutaneous treatment of a ruptured pulmonary artery pseudoaneurysm using N-butyl cyanoacrylate.
- Author
-
David A, Liberge R, Perret C, Frampas E, and Douane F
- Subjects
- Humans, Male, Middle Aged, Aneurysm, False diagnostic imaging, Aneurysm, False therapy, Aneurysm, Ruptured diagnostic imaging, Aneurysm, Ruptured therapy, Embolization, Therapeutic methods, Enbucrilate administration & dosage, Pulmonary Artery, Tomography, X-Ray Computed
- Published
- 2017
- Full Text
- View/download PDF
42. Whole-lung torsion complicating double lung transplantation: CT features.
- Author
-
David A, Liberge R, Corne F, and Frampas E
- Subjects
- Adult, Cystic Fibrosis surgery, Humans, Imaging, Three-Dimensional, Lung Diseases complications, Male, Tomography, X-Ray Computed, Torsion Abnormality complications, Lung Diseases diagnostic imaging, Lung Transplantation, Torsion Abnormality diagnostic imaging
- Published
- 2016
- Full Text
- View/download PDF
43. Pulmonary nodules and masses in lung transplant recipients: clinical and CT findings.
- Author
-
Morla O, Liberge R, Arrigoni PP, and Frampas E
- Subjects
- Adult, Aged, Diagnosis, Differential, Female, Humans, Male, Middle Aged, Retrospective Studies, Young Adult, Image-Guided Biopsy methods, Multidetector Computed Tomography methods, Multiple Pulmonary Nodules diagnosis, Transplant Recipients
- Abstract
Objectives: The purpose of this study was to review the clinical and CT findings of pulmonary nodules and masses in lung transplant recipients and to determine distinguishing features among the various aetiologies., Methods: This retrospective study included 106 lung transplant recipients who had a chest CT performed over a 7-year period in a single institution., Results: Twenty-four cases of pulmonary nodules and masses were observed on CT. Among the single lesions, three (50%) were due to infections, one (17%) to organizing pneumonia, and two (33%) remained of undetermined origin. Among the multiple lesions, 14 (78%) were due to infection, three to post-transplant lymphoproliferative disorder (17%), and one to bronchogenic carcinoma (5%). The two main microorganisms were P. aeruginosa and Aspergillus spp. Among 12 solid nodules > 1 cm, four (33%) were due to malignancy: three post-transplant lymphoproliferative disorders (25%), and one bronchogenic carcinoma (8%). Among five cavitary nodules four (80%) were due to aspergillosis., Conclusion: Infection is the most frequent aetiology of pulmonary nodules and masses in lung transplant recipients, but other causes such as post-transplant lymphoproliferative disorder, bronchogenic carcinoma, or organizing pneumonia should be considered., Key Points: Pulmonary nodules and masses are frequent in lung transplant recipients. Infection is the most frequent aetiology of solitary and multiple pulmonary nodules. Differential diagnosis includes post-transplant lymphoproliferative disorder, bronchogenic carcinoma, and organizing pneumonia. Clinical and CT findings are often non-specific. CT findings may be suggestive of some aetiologies that justify a biopsy.
- Published
- 2014
- Full Text
- View/download PDF
44. Polytetrafluoroethylene-covered nitinol stent graft for treatment of carotid artery blowout syndrome in head and neck cancer patients.
- Author
-
Hakime A, Khoury E, Hameg A, Liberge R, Deschamps F, Farouil G, Joskin J, Tselikas L, Temam S, Janot F, and De Baere T
- Subjects
- Adult, Aged, Alloys, Female, Head and Neck Neoplasms radiotherapy, Humans, Male, Middle Aged, Polytetrafluoroethylene, Retrospective Studies, Risk Factors, Rupture, Spontaneous, Syndrome, Blood Vessel Prosthesis Implantation methods, Carotid Artery Diseases etiology, Carotid Artery Diseases surgery, Head and Neck Neoplasms complications, Stents
- Abstract
Objectives/hypothesis: To evaluate the efficacy, tolerance, and outcomes of covered stents in the treatment of carotid blowout syndrome (CBS) in head and neck cancer patients., Study Design: Individual retrospective cohort study., Methods: We retrospectively reviewed the medical and image files of all 20 consecutive head and neck cancer patients treated with covered stent grafts for CBS. Six acute, 12 impending, and two threatened cases of CBS were treated in patients who all had previously received radiation therapy. We evaluated the feasibility, hemostatic efficacy, survival without bleeding, and complications., Results: The etiologies of CBS were as follows: group 1, 13 carotid axis (common or internal carotid artery) pseudoaneurysms and one rupture; group 2, six patients with no identifiable source of bleeding on angiography but with a threatened carotid axis on computed tomography (CT). In all patients, a polytetrafluoroethylene-covered nitinol stent graft (Fluency; Bard/Angiomed GmbH & Co, Karlsruhe, Germany) was successfully placed. All of the stents were patent at the end of the procedure. Immediate hemostasis was achieved in the six hemorrhagic cases. Immediate transient ischemic attacks were observed in two patients, and carotid sinus syndrome was observed in one patient. Post-treatment bleeding was observed in five patients in group 2 and no patients in group 1. Survival without bleeding was 251 days in group 1 and 35 days in group 2. During follow-up, three asymptomatic stent thromboses occurred at a mean of 58 days., Conclusions: Covered stent placement is highly feasible and proved effective without major complications in CBS due to carotid axis bleeding., (Copyright © 2013 The American Laryngological, Rhinological and Otological Society, Inc.)
- Published
- 2013
- Full Text
- View/download PDF
45. [Vertebrovertebral arteriovenous fistula diagnosis and treatment: report of 8 cases and review of the literature].
- Author
-
Madoz A, Desal H, Auffray-Calvier E, Isnard J, Liberge R, Taverneau C, and De Kersaint-Gilly A
- Subjects
- Adult, Aged, Female, Humans, Male, Middle Aged, Arteriovenous Fistula diagnosis, Arteriovenous Fistula therapy, Jugular Veins pathology, Vertebral Artery pathology
- Abstract
Vertebrovertebral Arteriovenous Fistula (V.V.A.V.F.) is a relatively rare entity. It may be an incidental finding or be detected in patients presenting with pulsatile tinnitus, cervical bruit, or vertebro-basilar insufficiency. It can be spontaneous but it most frequently is post-traumatic in etiology. The authors report 8 patients, 4 women and 4 men aged between 20 to 77 years, with 4 post-traumatic V.V.A.V.F. and 4 spontaneous V.V.A.V.F. that were seen over a 15 year period. Imaging work-up included Doppler US (n=4), MRI 9n=3) and angiography (n=8). Seven of 8 patients were treated successfully using an endovascular technique (5 with balloon occlusion, 1 with coil embolization and 1 using a mechanical maneuver), without complication or recurrence, except in one case. We compare our results with published reports from the literature and review the underlying pathology and management strategies of V.V.A.V.F.
- Published
- 2006
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.